Trials / Recruiting
RecruitingNCT06706557
Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
A Pilot Study on the Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- European Institute of Oncology · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Pilot study on circulating tumor DNA (ctDNA) in advanced/metastatic breast cancer with low levels of HER2 expression (HER2 low)
Detailed description
Prospective single-center feasibility study of 30 patients with carcinoma breast with low levels of HER2 expression, defined as 1+ or 2+ expression levels by the IHC technique (immunohistochemistry) and the gene not amplified by the ISH test (in situ hybridization)
Conditions
Timeline
- Start date
- 2024-01-11
- Primary completion
- 2026-12-31
- Completion
- 2030-12-31
- First posted
- 2024-11-26
- Last updated
- 2026-03-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06706557. Inclusion in this directory is not an endorsement.